Literature DB >> 29071390

[Current indications for left atrial appendage occlusion].

Clemens Jilek1, Thorsten Lewalter2.   

Abstract

Among patients with atrial fibrillation, the bleeding risk is linked to the stroke risk. Left atrial appendage (LAA) occlusion may reduce bleeding risk in high-risk patients. On the basis of a literature analysis and the Consensus Document of European Heart Rhythm Association (EHRA), the indications for a LAA occluder are clarified and a clear decision strategy for daily clinical practice is presented.

Entities:  

Keywords:  Atrial fibrillation; Indication; Left atrial appendage occlusion; Prevention; Stroke

Mesh：

Year:  2017        PMID： 29071390     DOI： 10.1007/s00399-017-0531-1

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  42 in total

1.  Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Emily C O'Brien; DaJuanicia N Holmes; Jack E Ansell; Larry A Allen; Elaine Hylek; Peter R Kowey; Bernard J Gersh; Gregg C Fonarow; Christopher R Koller; Michael D Ezekowitz; Kenneth W Mahaffey; Paul Chang; Eric D Peterson; Jonathan P Piccini; Daniel E Singer
Journal:  Am Heart J       Date:  2014-01-04       Impact factor: 4.749

2.  Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.

Authors:  Benjamin A Steinberg; Melissa A Greiner; Bradley G Hammill; Lesley H Curtis; Emelia J Benjamin; Susan R Heckbert; Jonathan P Piccini
Journal:  Cardiovasc Ther       Date:  2015-08       Impact factor: 3.023

3.  Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial.

Authors:  Maximilian Y Emmert; Gilbert Puippe; Stephan Baumüller; Hatem Alkadhi; Ulf Landmesser; Andre Plass; Dominique Bettex; Jacques Scherman; Jürg Grünenfelder; Michele Genoni; Volkmar Falk; Sacha P Salzberg
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-08       Impact factor: 4.191

4.  Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias.

Authors:  Andreas Rillig; Roland R Tilz; Tina Lin; Thomas Fink; Christian-H Heeger; Anita Arya; Andreas Metzner; Shibu Mathew; Erik Wissner; Hisaki Makimoto; Peter Wohlmuth; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

5.  Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.

Authors:  Dhanunjaya Lakkireddy; Muhammad R Afzal; Randall J Lee; Hosakote Nagaraj; David Tschopp; Brett Gidney; Christopher Ellis; Eric Altman; Brian Lee; Saibal Kar; Nitish Bhadwar; Mauricio Sanchez; Varuna Gadiyaram; Rudolph Evonich; Abdi Rasekh; Jie Cheng; Frank Cuoco; Sheetal Chandhok; Sampath Gunda; Madhu Reddy; Donita Atkins; Sudharani Bommana; Phillip Cuculich; Douglas Gibson; Jayant Nath; Ryan Ferrell; Earnest Matthew; David Wilber
Journal:  Heart Rhythm       Date:  2016-02-09       Impact factor: 6.343

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.

Authors:  Apostolos Tzikas; David R Holmes; Sameer Gafoor; Carlos E Ruiz; Carina Blomström-Lundqvist; Hans-Christoph Diener; Riccardo Cappato; Saibal Kar; Randal J Lee; Robert A Byrne; Reda Ibrahim; Dhanunjaya Lakkireddy; Osama I Soliman; Michael Nabauer; Steffen Schneider; Johannes Brachmann; Jeffrey L Saver; Klaus Tiemann; Horst Sievert; A John Camm; Thorsten Lewalter
Journal:  Europace       Date:  2016-08-18       Impact factor: 5.214

9.  Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.

Authors:  Vilhelm Sjögren; Björn Byström; Henrik Renlund; Peter J Svensson; Jonas Oldgren; Bo Norrving; Anders Själander
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Authors:  Ajay K Kakkar; Iris Mueller; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gregory Y H Lip; Lorenzo G Mantovani; Alexander G G Turpie; Martin van Eickels; Frank Misselwitz; Sophie Rushton-Smith; Gloria Kayani; Peter Wilkinson; Freek W A Verheugt
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.